Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice - Quiz - MDSpire

Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice

  • By

  • Claire Victoria Ong

  • Wolfram Samlowski

  • February 11, 2025

  • 0 min

Share

Original Source(s)

Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice

  • by Claire Victoria Ong, Wolfram Samlowski

  • February 11, 2025

Related Content

TIL cell therapy in HIV positive patient with metastatic melanoma: case report

Potential targets for boron transport in boron neutron capture therapy

Matrix metalloproteinase expression in basal cell carcinoma, squamous carcinoma, and melanoma: diagnostic and prognostic potential